The bipolar depression market is anticipated to increase during the forecast period (2026--2036), owing to the rise in the launch of emerging therapies such as Azetukalner (Xenon Pharmaceuticals), ...

The FDA approved milsaperidone (Bysanti) tablets as first-line therapy for adults with schizophrenia and manic or mixed episodes related to bipolar I disorder, Vanda Pharmaceuticals announced on ...

The FDA has approved Bysanti (milsaperidone) tablets for the treatment of bipolar I disorder and schizophrenia in adults. The drug is indicated as a first-line therapy for acute manic or mixed ...

WASHINGTON, Sept 12 (Reuters) - The breast cancer pill tamoxifen helped treat the "manic" symptoms of bipolar disease, U.S. government researchers said on Wednesday. Although tamoxifen may be too ...

When lithium or valproate aren't enough, ‘add-on’ treatments like atypical antipsychotics can help. Discover 7 options to discuss with your doctor.

Imagine you're a 20 year old university student without any prior history of bipolar symptoms. Thus far, you've been on top of your game—attendance at an elite university, excellent grades, numerous ...

ROCHESTER, Minn. -- A preliminary study of 85 patients with bipolar disorder shows that a drug used to treat patients with sleep disorders might also control the depressive symptoms associated with ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Compared with ...